Dr. Andrea Love wrote about the lack of basic scientific knowledge among the public, noting that only about 28 percent of people possess it. She highlighted the consequences of this, emphasizing how it can negatively affect people’s decisions and lives.
Many of the articles I have written have dealt with scientific knowledge in one form or another. My comments on the FDA and drug approvals, Alzheimer’s and cancer screening blood tests, …
The room went quiet the way rooms do before something consequential, when conversation thins and all you can hear is the pulse in your ears.
“Captain Kumar,” the instructor said, “you have an in-flight engine failure. What do you do?”
I stood at attention, spine locked, as my classmates turned toward me with the focused expectation of a clinical team evaluating a tenuous presentation. A bead of sweat slid down my temple. …
Holding my mother in my arms as she took her last breath changed the way I understand care. That moment, Easter Monday in Canada, was heartbreaking and transformative. Her unwavering faith and peaceful passing contrasted sharply with the confusion that followed when CPR began despite her do-not-resuscitate (DNR) order. I felt helpless.
The experience became the catalyst for my commitment to advocacy and ethical clarity. It taught me that even well-intentioned …
We’ve been thinking about remote patient monitoring (RPM) the wrong way.
Picture this. A patient comes home from the hospital after a cardiac scare. They’ve got a smart scale on their chest, maybe a blood pressure cuff on the counter, and a nurse scheduled to stop by later in the week. The care team, the patient, and the tech are all working together in the hopes that things don’t get worse.
The …
In the early 2000s, I included “drugs for mild hypertension” in my book, Money-Driven Medicine: Tests and Treatments That Don’t Work. By 2007, I proposed a Cochrane systematic review of randomized controlled trials (RCTs) to settle the debate. Cochrane is widely considered the “gold standard” of evidence-based medicine; its reviews can shift global clinical practice and multibillion-dollar drug markets.
In 2012, Cochrane published the systematic review of Pharmacotherapy for …
For decades, many have documented the decline of the physical exam. As imaging grew more powerful, labs more precise, and algorithms more accurate, the stethoscope and reflex hammer faded in importance. Some even speculated that technology would eventually make hands-on diagnostic skills obsolete.
But the next era of medicine may flip that prediction on its head.
Picture a future where artificial intelligence participates in nearly all patient management decisions. This seems inevitable …
With the holiday season upon us, joy, warmth, and delicious food fill our homes. While we enjoy those festival meals, our own “life-highway” vessels quietly shoulder the burden of all the fats and sugars we consume. Alongside the happiness of the season comes an overlooked strain on our arteries. What strikes me even more, as a vascular specialist, is a recent study from the University Hospital at Downstate in …
Three weeks after giving birth, you are hit with a blinding headache and fading vision. The next available appointment with your doctor is two weeks away. You finally go to your doctor, and your blood pressure has already reached a dangerous level without you even realizing.
The solution is straightforward. A home blood pressure monitor costs between $69 and $169. Yet most insurers will not cover it because many states do …
Every week in clinic, I meet patients who carry lab results like heavy burdens. Their cholesterol is “slightly high,” their thyroid level is “borderline,” or their blood sugar is “just above normal.” They arrive anxious, wanting certainty: Do I need treatment? Am I sick?
The truth is, much of medicine exists in the gray zone (values that are not clearly normal, but not clearly dangerous either).
What the research tells us
Borderline numbers …
At the end of a clinic visit, the conversation often turns to lifestyle: eat healthier, exercise more, cut back on alcohol, sleep better. Patients nod, agree, and walk out the door.
And too often, little changes.
Why does advice that seems so straightforward rarely stick? The answer lies in the gap between medical instruction and human behavior.
The limits of good intentions
Research has shown that simply giving advice is rarely enough. A 2019 …
Anyone close to me knows orthopedics has never been my cup of tea. I rarely studied it properly; somehow, my enthusiasm always remained low. No offence to the subject, but maybe it started the day I saw my best friend’s forearm break. Fractures have always made me uncomfortable. During one of our postings, we were asked to do a case presentation. A patient was assigned to us, and it happened …
Every cardiology clinic has them: patients with swollen, aching legs and bulging varicose veins. We talk about conservative management: exercise, leg elevation, and, of course, compression stockings. And almost without fail, patients smile politely, nod, and then admit at the next visit: “I couldn’t wear them. They’re too tight, too hot, too uncomfortable.”
The paradox of a simple solution
Compression stockings are one of the most effective noninvasive treatments for varicose veins …
It happens almost every clinic day. A patient walks in, sits down for their vital signs, and their blood pressure reads higher than expected. Sometimes much higher. Moments later, when I retake it myself after we’ve talked for a few minutes, it’s 20 or 30 points lower.
“But, doctor, I check it at home and it’s never this high!”
They are right. This is the phenomenon of white coat hypertension, blood pressure …
ADVERTISEMENT
I just read the new Cleveland Clinic Journal of Medicine introduction by its editor-in-chief, and it’s laying out the usual playbook: demonize lipoprotein(a) (Lp(a)), list all the terrible things it does, and hint that salvation is around the corner, pending results of a major pharmaceutical trial, of course.
It’s a neat narrative arc.
But it’s incomplete.
What’s missing is the one question almost no cardiology article seems willing to ask:
Why does Lp(a) exist …
He came to my office holding the results of his coronary CT scan. His eyes went immediately to the numbers, his voice tense: “Doctor, my FFR is 0.86. Do I need a stent?”
This is not an unusual question anymore. Coronary CT angiography with fractional flow reserve (FFR-CT) is rapidly becoming a common tool in cardiology. It gives us noninvasive insight into whether a coronary lesion is functionally significant. In plain …
For decades, cholesterol (LDL, HDL, triglycerides) has been the central focus of cardiovascular prevention. But in recent years, another player has emerged: lipoprotein(a), or Lp(a).
Many patients have never heard of it, yet research shows it may be one of the most important genetic risk factors for heart disease.
What is lipoprotein(a)?
Lipoprotein(a) is a particle in the blood similar to LDL cholesterol, but with an added protein called apolipoprotein(a). This structure makes …
I just read yet another article praising the new messiah of cardiology (Lipoprotein(a)) and urging every physician in America to start testing for it. The tone was familiar: solemn, scientific, and a little evangelical.
The message? “Measure Lp(a) once in every patient.”
The subtext? “Because we finally found the missing piece.”
If this feels like déjà vu, that’s because it is. We’ve been here before: first with total cholesterol, then LDL, then HDL …
As an internist and lipidologist, I’ve spent decades parsing data on statins, ezetimibe, PCSK9 inhibitors, and the endless parade of “LDL-lowering breakthroughs.” Yet the most potent, and perhaps the most underappreciated, intervention to prevent heart attacks each winter doesn’t come from a cardiology journal or a pharmaceutical rep. It comes from your local pharmacy fridge. For years, I’ve told my patients that getting a flu shot may prevent a heart …
A glass of wine with dinner. A cocktail on a Friday evening. A few beers over the weekend. For many of my patients, alcohol is woven seamlessly into daily life: a social lubricant, a way to unwind, even something they’ve been told might be “heart-healthy.”
Yet, in my clinic, I see the other side. A patient who comes in with fluctuating blood pressure, convinced their readings must be wrong. Another who …
Lipoprotein(a) [Lp(a)] was, until recently, an underrecognized cardiovascular risk factor. However, extensive research over the last 15 years (including vast genome-wide association studies) has confirmed an independent, causal link between elevated lipoprotein(a) levels and atherosclerotic cardiovascular disease (ASCVD). The science has shown that, despite their small size, Lp(a) particles can have a substantial health impact, and as many as one in every five individuals worldwide has elevated levels (defined as …
Get free updates delivered free to your inbox.
